If past natural disasters have taught us anything about their effects on pregnant women and developing babies, it is to pay close attention, for the added stress will surely have an impact on them. Amanda Venta, associate ...
Mar 9, 2021
0
0
Interleukin (IL)-15 is a cytokine with different modes of action, and a new article describes why it is important to selectively target the mode of action of the cytokine rather than IL-15 itself to inhibit its activity. ...
Jan 23, 2023
0
1
An ongoing study is looking at the relationship between cytokines in saliva and COVID-19 infection to help predict the severity of infection. In a preliminary analysis of saliva samples from 150 children, the researchers ...
Oct 8, 2021
0
4
An important discovery has been made by Professor Hyug Moo Kwon and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Jaeseok Yang from Yonsei University. Their study sheds ...
Sep 12, 2023
0
11
For a tumour to grow, it must develop blood vessels that supply nutrients and oxygen. Preventing tumour vascularization is therefore an interesting anti-tumour therapy that has been explored over the last ten years. But how ...
Feb 2, 2018
0
1
Cytokines are proteins secreted by several types of immune cells in response to infection, inflammation, or injury. Interleukin-17 (IL-17) is one such cytokine that causes inflammation, by controlling the production of other ...
Apr 3, 2017
0
0
Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update ...
Jul 21, 2023
0
1
Chimeric antigen receptor T cells—CAR T cells for short—are immune cells (T cells) that are taken from the body and genetically modified outside the body in the laboratory using transport vehicles for the genes to be ...
Mar 22, 2024
0
0
A new research paper was published in Oncotarget, titled "The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells."
Jul 26, 2023
0
1
The U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Apr 10, 2024
0
1
